Fluoxetine-Induced Dyskinesia in a Pediatric Patient: A Case Report and Literature Review on Implications of Polypharmacy and Serotonergic Regulation
Open Access
- 1 January 2025
- journal article
- review article
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- No. Early Acce
Abstract
Movement disorders associated with psychiatric medications are primarily related to the side effects of dopamine receptor-blocking drugs, which are mostly antipsychotic medications. These side effects are acute dystonic reactions, akathisia, dyskinesia, neuroleptic malignant syndrome, parkinsonism, and various tardive syndromes. Dyskinetic movements are characterized by hyperkinetic, repetitive movements of the extremities, facial, and perioral muscles. In rare cases, dyskinetic movements may occur with the use of selective serotonin reuptake inhibitors (SSRIs) through an indirect D2 blocking mechanism. In this case report, dyskinesia observed after increasing the dose of fluoxetine in a patient using methylphenidate and risperidone was presented. It was thought that the SSRI inhibited dopamine activity through dopamine receptor antagonism and that SSRIs may increase risperidone concentrations by inhibiting CYP450 metabolism. There are few cases reported in the literature regarding SSRI-induced dyskinesia, information is limited on this subject. This case report highlights the potential dyskinesia side effect of SSRIs.Keywords
This publication has 25 references indexed in Scilit:
- Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017Pharmacopsychiatry, 2017
- Drug-Induced Extrapyramidal SyndromesPsychiatric Clinics of North America, 2016
- Fluoxetine Potentiates Methylphenidate-Induced Gene Regulation in Addiction-Related Brain Regions: Concerns for Use of Cognitive Enhancers?Biological Psychiatry, 2010
- The 5-HT7 receptor is involved in allocentric spatial memory information processingBehavioural Brain Research, 2009
- The history of dopamine and levodopa in the treatment of Parkinson's diseaseMovement Disorders, 2008
- Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An updateClinical Therapeutics, 2008
- The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteersPsychopharmacology, 2006
- Two cases of risperidone-induced tardive dyskinesia and a review of the literatureEuropean Psychiatry, 1999
- Fluoxetine Induced DyskinesiaAustralian & New Zealand Journal of Psychiatry, 1994
- Tardive Dyskinesia—Reversible and PersistentArchives of General Psychiatry, 1979